Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution-Reference-Cited by-同舟云学术

Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution

Published:2019-11-06 Issue:1 Volume:57 Page:115-116
ISSN:0940-5429
Container-title:Acta Diabetologica
language:en
Short-container-title:Acta Diabetol

Author:

Antonazzo Ippazio Cosimo,Poluzzi Elisabetta,Forcesi Emanuele,Salvo Francesco,Pariente Antoine,Marchesini Giulio,De Ponti Fabrizio,Raschi Emanuel^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00592-019-01441-3.pdf

Reference5 articles.

1. Kuss O, Rathmann R (2019) A missed protective drug-drug-interaction of DPP-4 inhibitors and statins on myopathy risk. Acta Diabetol. https://doi.org/10.1007/s00592-019-01440-4

2. Antonazzo IC, Poluzzi E, Forcesi E et al (2019) Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug-drug interactions through the FDA adverse event reporting system. Acta Diabetol. https://doi.org/10.1007/s00592-019-01378-7

3. Fadini GP, Bonora BM, Mayur S, Rigato M, Avogaro A (2018) Dipeptidyl peptidase-4 inhibitors moderate the risk of genitourinary tract infections associated with sodium-glucose co-transporter-2 inhibitors. Diabetes Obes Metab 20:740–744

4. Raschi E, Poluzzi E, Salvo F et al (2018) Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: what a clinician should know on disproportionality analysis of spontaneous reporting systems. Nutr Metab Cardiovasc Dis 28:533–542

5. Thakrar BT, Grundschober SB, Doessegger L (2007) Detecting signals of drug-drug interactions in a spontaneous reports database. Br J Clin Pharmacol 64:489–495

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems;Frontiers in Drug Safety and Regulation;2024-01-26

2. Spotlight commentary: The value of spontaneous reporting systems to detect (the lack of) clinically relevant drug–drug interactions in clinical practice;British Journal of Clinical Pharmacology;2023-05-24

3. Author’s Reply to Kuss and Rathmann’s Comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data”;Drug Safety;2023-04-15

4. Pharmacovigilance‐based drug repurposing: The search for inverse signals via OpenVigil identifies putative drugs against viral respiratory infections;British Journal of Clinical Pharmacology;2021-05-05

5. Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance;Targeted Oncology;2020-07-28